# Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars

> **NCT06237231** · PHASE3 · NOT_YET_RECRUITING · sponsor: **EMS** · enrollment: 252 (estimated)

## Conditions studied

- Moderate Pain
- Severe Pain

## Interventions

- **DRUG:** DIT112
- **DRUG:** DIPYRONE
- **DRUG:** TRAMADOL
- **DRUG:** DIT112 Placebo
- **DRUG:** Dipyrone Placebo
- **DRUG:** Tramadol Placebo

## Key facts

- **NCT ID:** NCT06237231
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-15
- **Primary completion:** 2025-03-15
- **Final completion:** 2027-04-10
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237231, "Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06237231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*